RxDoctor Payments Data

Edward Lebrija, DPM

Foot & Ankle Surgery · Peru, INNPI 1932112000

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $28,314 of the $39,767 with a category attached, or 71.2%. 18 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 45.6% of the total. Reporting peaked in 2020 at $9,463 and has fallen 72.3% since, to $2,620 in 2025. Among foot & ankle surgery clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$39,767in general payments, 2019–2025

Across 159 payments — averaging $250.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$18K
  • Gramercy Extremity Orthopedics LLC$15K
  • Stryker$3K
  • Arthrex$2K
  • Integra Lifesciences Corporation$379
  • Smith+Nephew$322
  • plus $1K from 12 others

What the payments were for

  • Royalty or licence$8302%
  • Consulting fees$28,31471%
  • Speaking & faculty fees$2,0005%
  • Travel & lodging$4,50511%
  • Food & beverage$4,11910%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,767 in reported general payments places this provider in the 90th percentile of 212 foot & ankle surgery providers in Indiana.

See all foot & ankle surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$100,373
Medicare patients
418
Services billed
1,474

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
QutenzaCapsaicin/Skin Cleanser12$43,708
Nitro-BidNitroglycerin15$801
Ciclopirox15$755
Terbinafine Hcl24$626
Ammonium Lactate42$499
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen27$343
Methylprednisolone49$294
CiclopiroxCiclopirox Olamine22$229
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$225
Cephalexin28$154
Gabapentin13$138
Meloxicam14$123
Levofloxacin16$51

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Peru

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →